Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2013 | 02-2013 | 11-2012 | 08-2012 | 05-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 537 | 493 | 529 | 292 | 548 |
| Depreciation Amortization | 217 | 164 | 111 | 54 | 180 |
| Income taxes - deferred | 9 | N/A | N/A | N/A | N/A |
| Accounts receivable | 326 | 691 | -313 | -176 | -534 |
| Other Working Capital | 604 | 822 | -249 | -43 | -606 |
| Other Operating Activity | -299 | -674 | 320 | 203 | 560 |
| Operating Cash Flow | $1,394 | $1,496 | $397 | $330 | $147 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -257 | -249 | -242 | -65 | -165 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -50 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 52 |
| Investing Cash Flow | $-257 | $-249 | $-242 | $-65 | $-113 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -43 | N/A | N/A | N/A | 43 |
| Debt Repayment | N/A | -43 | -43 | -43 | -35 |
| Common Stock Issued | 302 | 40 | 6 | 0 | 48 |
| Financing Cash Flow | $259 | $-3 | $-37 | $-43 | $55 |
| Exchange Rate Effect | -3 | -3 | -1 | 0 | -2 |
| Beginning Cash Position | 1,077 | 1,077 | 1,077 | 1,077 | 989 |
| End Cash Position | 2,470 | 2,319 | 1,194 | 1,300 | 1,077 |
| Net Cash Flow | $1,393 | $1,241 | $117 | $222 | $88 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,394 | 1,496 | 397 | 330 | 147 |
| Capital Expenditure | -257 | -249 | -242 | -65 | -165 |
| Free Cash Flow | 1,137 | 1,247 | 155 | 265 | -17 |